Single domain antibodies directed against ebola virus VP24
AssigneeSingh Biotechnology, LLC
InventorSunanda Singh
Life of this patent
Estimating the term…
Abstract
This invention provides compositions and methods to treat a condition or disease without the use of exogenous targeting sequences or chemical compositions. The present invention relates to single-domain antibodies (sdAbs), proteins and polypeptides comprising the sdAbs that are directed against targets that cause a condition or disease. The invention also includes nucleic acids encoding the sdAbs, proteins and polypeptides, and compositions comprising the sdAbs. The invention includes the use of the compositions, sdAbs, and nucleic acids encoding the sdAbs for prophylactic, therapeutic or diagnostic purposes.
Claims2
An anti-Ebola VP24 sdAb, wherein the anti-Ebola VP24 sdAb comprises the amino acid sequence as set forth in SEQ ID NO:
- 55.
An isolated polypeptide, the isolate polypeptide comprising the amino acid sequence as set forth in SEQ ID NO:55.
Dependencies are inferred from the claim text.